Myles David C.
SEC insider (Form 3/4/5 filer). CIK 0001831216. CH. DISCOV. & NON-CLIN DEV OFF at Olema Pharmaceuticals, Inc. (OLMA). 18 reported Form 4/5 transactions since Sep 2024; latest on Feb 2, 2026. Located in SAN FRANCISCO, CA.
Companies Myles David C. has filed insider reports for
- Olema Pharmaceuticals, Inc. (OLMA): Officer, CH. DISCOV. & NON-CLIN DEV OFF
Myles David C.
CIK: 0001831216
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Olema Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Feb 2, 2026OLMA
Olema Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
250K shares- - Feb 2, 2026OLMA
Olema Pharmaceuticals, Inc.
AwardDirectPerformance Stock Options (Right to Buy)
106.3K shares- - Jan 14, 2026OLMA
Olema Pharmaceuticals, Inc.
SaleDirect15K shares at avg. $28.60$429K - Jan 14, 2026OLMA
Olema Pharmaceuticals, Inc.
ExerciseDirect50K shares at avg. $4.87$244K - Jan 14, 2026OLMA
Olema Pharmaceuticals, Inc.
SaleDirect35K shares at avg. $28.99$1.0M - Jan 13, 2026OLMA
Olema Pharmaceuticals, Inc.
ExerciseDirect50K shares at avg. $4.87$244K - Jan 13, 2026OLMA
Olema Pharmaceuticals, Inc.
SaleDirect49.8K shares at avg. $27.60$1.4M - Jan 13, 2026OLMA
Olema Pharmaceuticals, Inc.
SaleDirect200 shares at avg. $28.49$6K - Jan 12, 2026OLMA
Olema Pharmaceuticals, Inc.
SaleIndirect10K shares at avg. $28.34$283K - Dec 19, 2025OLMA
Olema Pharmaceuticals, Inc.
GiftDirect9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 2, 2026 | OLMA Olema Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 250,000 | - | - | Direct |
| Feb 2, 2026 | OLMA Olema Pharmaceuticals, Inc. | Award Performance Stock Options (Right to Buy) | 106,250 | - | - | Direct |
| Jan 14, 2026 | OLMA Olema Pharmaceuticals, Inc. | Sale | 14,997 | $28.60 | $428,914 | Direct |
| Jan 14, 2026 | OLMA Olema Pharmaceuticals, Inc. | Exercise | 50,000 | $4.87 | $243,500 | Direct |
| Jan 14, 2026 | OLMA Olema Pharmaceuticals, Inc. | Sale | 35,003 | $28.99 | $1,014,737 | Direct |
| Jan 13, 2026 | OLMA Olema Pharmaceuticals, Inc. | Exercise | 50,000 | $4.87 | $243,500 | Direct |
| Jan 13, 2026 | OLMA Olema Pharmaceuticals, Inc. | Sale | 49,800 | $27.60 | $1,374,480 | Direct |
| Jan 13, 2026 | OLMA Olema Pharmaceuticals, Inc. | Sale | 200 | $28.49 | $5,698 | Direct |
| Jan 12, 2026 | OLMA Olema Pharmaceuticals, Inc. | Sale | 10,000 | $28.34 | $283,400 | Indirect |
| Dec 19, 2025 | OLMA Olema Pharmaceuticals, Inc. | Gift | 9,000 | - | - | Direct |
1-10 of 18 transactions